Folkman J, Klagsbrun M
Science. 1987 Jan 23;235(4787):442-7. doi: 10.1126/science.2432664.
Within the past 2 years, several angiogenic factors have been fully purified, their amino acid sequences determined, and their genes cloned. These polypeptides include acidic and basic fibroblast growth factor, angiogenin, and transforming growth factors alpha and beta. Other less well characterized angiogenesis factors have also been isolated, some of which are lipids. This article traces the discovery of the angiogenic factors and describes their possible significance in understanding growth regulation of the vascular system. When evaluated according to their putative targets, they appear to fall into two groups: those that act directly on vascular endothelial cells to stimulate locomotion or mitosis, and those that act indirectly by mobilizing host cells (for example, macrophages) to release endothelial growth factors. In addition to their presence in tumors undergoing neovascularization, the same angiogenic peptides are found in many normal tissues where neovascularization is not occurring. This suggests that physiological expression of angiogenic factors is tightly regulated. In addition to the persistent angiogenesis induced by tumors, it now appears that a variety of nonneoplastic diseases, previously thought to be unrelated, can be considered as "angiogenic diseases" because they are dominated by the pathologic growth of capillary blood vessels.
在过去两年中,几种血管生成因子已被完全纯化,其氨基酸序列已确定,基因也已克隆。这些多肽包括酸性和碱性成纤维细胞生长因子、血管生成素以及转化生长因子α和β。其他一些特征不太明确的血管生成因子也已被分离出来,其中一些是脂质。本文追溯了血管生成因子的发现过程,并描述了它们在理解血管系统生长调节方面的可能意义。根据其假定的作用靶点进行评估时,它们似乎可分为两类:一类直接作用于血管内皮细胞以刺激其运动或有丝分裂,另一类则通过动员宿主细胞(如巨噬细胞)间接发挥作用,促使其释放内皮生长因子。除了在正在进行新血管形成的肿瘤中存在外,在许多未发生新血管形成的正常组织中也发现了同样的血管生成肽。这表明血管生成因子的生理表达受到严格调控。除了肿瘤诱导的持续性血管生成外,现在看来,多种以前被认为无关的非肿瘤性疾病,可被视为“血管生成性疾病”,因为它们以毛细血管的病理性生长为主导。